About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 320767, 6 pages
http://dx.doi.org/10.1155/2014/320767
Review Article

Streamlining Cutaneous Melanomas in Young Women of the Belgian Mosan Region

1Department of Dermatopathology, Unilab Lg, University Hospital of Liège, 4000 Liège, Belgium
2Dermatology Unit, Diagnostic Centre, 4800 Verviers, Belgium
3INTELSIG Laboratory, Montefiore Institute, University of Liège, 4000 Liège, Belgium

Received 16 January 2014; Accepted 24 January 2014; Published 25 February 2014

Academic Editor: Gérald E. Piérard

Copyright © 2014 Trinh Hermanns-Lê and Sébastien Piérard. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Piérard-Franchimont, I. Uhoda, and G. E. Piérard, “Cutaneous cancers in the Mosan region and Ardennes of Belgium,” Dermatology, vol. 198, no. 2, pp. 187–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. E. G. Little and M. J. Eide, “Update on the current state of melanoma incidence,” Dermatologic Clinics, vol. 30, pp. 355–361, 2012.
  3. S. T. Chen, A. C. Geller, and H. Tsao, “Update on the epidemiology of melanoma,” Current Dermatology Report, vol. 2, no. 1, pp. 24–34, 2013. View at Publisher · View at Google Scholar
  4. S. Gandini, F. Sera, M. S. Cattaruzza et al., “Meta-analysis of risk factors for cutaneous melanoma. III: family history, actinic damage and phenotypic factors,” European Journal of Cancer, vol. 41, no. 14, pp. 2040–2059, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. E. Piérard, C. Piérard-Franchimont, and P. Delvenne, The Thousand and One Facets of Actinic Keratosis, Nova Science Publishers, Hauppage, NY, USA, 2013.
  6. J. Kaae, A. Andersen, H. A. Boyd, J. Wohlfahrt, and M. Melbye, “Reproductive history and cutaneous malignant melanoma: a comparison between women and men,” The American Journal of Epidemiology, vol. 165, no. 11, pp. 1265–1270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. de Vries, T. E. C. Nijsten, O. Visser et al., “Superior survival of females among 10 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site,” Annals of Oncology, vol. 19, no. 3, pp. 583–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Hajdarevic, M. Schmitt-Egenolf, C. Brulin, E. Sundbom, and Å. Hörnsten, “Malignant melanoma: gender patterns in care seeking for suspect marks,” Journal of Clinical Nursing, vol. 20, no. 17-18, pp. 2676–2684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. J. Coups, C. J. Heckman, and S. L. Manne, “Melanoma risk and preventive behaviors among men and women,” The American Journal of Surgery, vol. 204, pp. 551–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Burton, M. E. Egger, A. R. Quillo et al., “Prognostic factors in young women with cutaneous melanoma,” The American Journal of Surgery, vol. 207, pp. 102–108, 2014. View at Publisher · View at Google Scholar
  11. L. D. Marrett, H. L. Nguyen, and B. K. Armstrong, “Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996,” International Journal of Cancer, vol. 92, no. 3, pp. 457–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. K. B. Reed, J. D. Brewer, C. M. Lohse, K. E. Bringe, C. N. Pruitt, and L. E. Gibson, “Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota,” Mayo Clinic Proceedings, vol. 87, no. 4, pp. 328–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. B. Lens, I. Rosdahl, A. Ahlbom et al., “Effect of pregnancy on survival in women with cutaneous malignant melanoma,” Journal of Clinical Oncology, vol. 22, no. 21, pp. 4369–4375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. T. O'Meara, R. Cress, G. Xing, B. Danielsen, and L. H. Smith, “Malignant melanoma in pregnancy: a population-based evaluation,” Cancer, vol. 103, no. 6, pp. 1217–1226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. de Vries, S. Houterman, M. L. G. Janssen-Heijnen et al., “Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands,” Annals of Oncology, vol. 18, no. 6, pp. 1110–1116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Bataille and E. de Vries, “Melanoma. Part 1: epidemiology, risk factors, and prevention,” The British Medical Journal, vol. 337, article a2249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Stensheim, B. Møller, T. van Dijk, and S. D. Fosså, “Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study,” Journal of Clinical Oncology, vol. 27, no. 1, pp. 45–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Gandini, S. Iodice, E. Koomen, A. D. Pietro, F. Sera, and S. Caini, “Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis,” European Journal of Cancer, vol. 47, no. 17, pp. 2607–2617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. C. Lowe, A. Saavedra, K. B. Reed et al., “Increasing indicence of melanoma among middle-aged adults: an epidemiologic study in Olmsted country Minnesota,” Mayo Clinic Proceedings, vol. 89, no. 1, pp. 52–59, 2014. View at Publisher · View at Google Scholar
  20. M. R. Karagas, T. A. Stukel, J. Dykes et al., “A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use,” The British Journal of Cancer, vol. 86, no. 7, pp. 1085–1092, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Althuis, B. Scoccia, E. J. Lamb et al., “Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs,” The American Journal of Obstetrics and Gynecology, vol. 193, no. 3, pp. 668–674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Kaae, A. Andersen, H. A. Boyd, J. Wohlfahrt, and M. Melbye, “Reproductive history and cutaneous malignant melanoma: a comparison between women and men,” The American Journal of Epidemiology, vol. 165, no. 11, pp. 1265–1270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. G. Hannibal, A. Jensen, H. Sharif, and S. K. Kjaer, “Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study,” Cancer Causes and Control, vol. 19, no. 7, pp. 759–765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Gandini, S. Iodice, E. Koomen, A. D. Pietro, F. Sera, and S. Caini, “Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis,” European Journal of Cancer, vol. 47, no. 17, pp. 2607–2617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. de Giorgi, A. Gori, S. Gandini et al., “Oestrogen receptor beta and melanoma: a comparative study,” The British Journal Dermatology, vol. 168, pp. 513–519, 2013. View at Publisher · View at Google Scholar
  26. L. Rylander, A. Rignell-Hydbom, H. Tinnerberg, and B. A. Jönsson, “Trends in human concentrations of endocrine disruptors: possible reasons and consequences,” Journal of Epidemiology & Community Health, 2013. View at Publisher · View at Google Scholar
  27. M. Grassi, L. Rizzo, and A. Farina, “Endocrine disruptors compounds, pharmaceuticals and personal care products in urban wastewater: implications for agricultural reuse and their removal by adsorption process,” Environmental Science and Pollution Research, vol. 20, no. 6, pp. 3616–3628, 2013. View at Publisher · View at Google Scholar
  28. L. Dewalque, C. Pirard, and C. Charlier, “Measurement of urinary biomarkers of parabens, benzophenone-3 and phthalates in a Belgian population,” BioMed Research International. In press.
  29. G. E. Piérard, T. Hermanns-Lê, L. Dewalque, C. Piérard-Franchimont, and C. Charlier, “New insights on slow-growing malignant melanomas in young Caucasian women,” International Journal of Oncology. In press.
  30. G. E. Piérard and C. Piérard-Franchimont, “HOX gene aberrant expression in skin melanoma,” Journal Skin Cancer, vol. 2012, Article ID 707260, 4 pages, 2012. View at Publisher · View at Google Scholar
  31. M. B. Lens and M. Dawes, “Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma,” The British Journal of Dermatology, vol. 150, no. 2, pp. 179–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Mellemkjær, S. Friis, J. H. Olsen et al., “Risk of second cancer among women with breast cancer,” International Journal of Cancer, vol. 118, no. 9, pp. 2285–2292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Stracci, D. D'Alò, T. Cassetti, M. Scheibel, and F. La Rosa, “Incidence of multiple primary malignancies in women diagnosed with breast cancer,” European Journal of Gynaecological Oncology, vol. 30, no. 6, pp. 661–663, 2009. View at Scopus
  34. P. T. Bradford, D. M. Freedman, A. M. Goldstein, and M. A. Tucker, “Increased risk of second primary cancers after a diagnosis of melanoma,” Archives of Dermatology, vol. 146, no. 3, pp. 265–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. E. Piérard, C. Piérard-Franchimont, T. Hermanns-Lê, and P. Delvenne, “Cutaneous malignant melanoma: only single disease?” Revue Médicale de Liège, vol. 67, pp. 458–460, 2012.
  36. D. S. Rigel, R. J. Friedman, A. W. Kopf, and D. Polsky, “ABCDE—an evolving concept in the early detection of melanoma,” Archives of Dermatology, vol. 141, no. 8, pp. 1032–1034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. G. E. Pierard, C. Pierard-Franchimont, J. Arrese Estrada et al., “Cyanoacrylate skin surface stripping: an improved approach for distinguishing dysplastic nevi from malignant melanomas,” Journal of Cutaneous Pathology, vol. 16, no. 4, pp. 180–182, 1989. View at Scopus
  38. G. E. Pierard, N. Ezzine-Sebai, B. Fazaa, N. Nikkels-Tassoudji, and C. Pierard-Franchimont, “Karyometry of malignant melanoma cells present in skin strippings,” Skin Research and Technology, vol. 1, no. 4, pp. 177–179, 1995. View at Scopus
  39. P. Carli, V. De Giorgi, A. Chiarugi et al., “Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study,” Journal of the American Academy of Dermatology, vol. 50, no. 5, pp. 683–689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Carli, V. De Giorgi, E. Crocetti et al., “Improvement of malignant/benign ratio in excised melanocytic lesions in the “dermoscopy era”: a retrospective study 1997–2001,” The British Journal of Dermatology, vol. 150, no. 4, pp. 687–692, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Skvara, L. Teban, M. Fiebiger, M. Binder, and H. Kittler, “Limitations of dermoscopy in the recognition of melanoma,” Archives of Dermatology, vol. 141, no. 2, pp. 155–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Argenziano, H. Kittler, G. Ferrara et al., “Slow-growing melanoma: a dermoscopy follow-up study,” The British Journal of Dermatology, vol. 162, no. 2, pp. 267–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Seidenari, C. Ferrari, S. Borsari et al., “The dermoscopic variability of pigment network in melanoma in situ,” Melanoma Research, vol. 22, no. 2, pp. 151–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Bassoli, C. Ferrari, S. Borsari et al., “Negative pigment network identifies a peculiar melanoma subtype and represents a clue to melanoma diagnosis: a dermoscopic study of 401 melanomas,” Acta Dermato-Venereology, vol. 93, pp. 650–655, 2013. View at Publisher · View at Google Scholar
  45. S. Seidenari, S. Bassoli, S. Borsari et al., “Variegated dermoscopy of in situ melanoma,” Dermatology, vol. 224, no. 3, pp. 262–270, 2012. View at Publisher · View at Google Scholar
  46. Y. Zhou, M. Smith, L. Smith, and R. Warr, “A new method describing border irregularity of pigmented lesions,” Skin Research and Technology, vol. 16, no. 1, pp. 66–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Ricco, T. Lettini, N. Arpaia et al., “Analytical and dimensional morphometry in early diagnosis cutaneous melanoma with dermoscopic images,” Analytical and Quantitative Cytology and Histology, vol. 33, no. 4, pp. 229–235, 2011. View at Scopus
  48. C. Piérard-Franchimont and G. E. Piérard, “The value of morphometry and of surface biopsy in the detection of malignant melanoma,” Revue Médicale de Liège, vol. 44, pp. 610–614, 1989.
  49. G. E. Piérard and C. Piérard-Franchimont, “Morphometric evaluation of the growth of nevi,” Annales de Dermatologie et de Vénéréologie, vol. 120, pp. 605–609, 1993.
  50. S. W. Menzies, “Cutaneous melanoma: making a clinical diagnosis, present and future,” Dermatologic Therapy, vol. 19, no. 1, pp. 32–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. S. W. Menzies, A. Gutenev, M. Avramidis, A. Batrac, and W. H. McCarthy, “Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions,” Archives of Dermatology, vol. 137, no. 12, pp. 1583–1589, 2001. View at Scopus
  52. H. Skvara, L. Teban, M. Fiebiger, M. Binder, and H. Kittler, “Limitations of dermoscopy in the recognition of melanoma,” Archives of Dermatology, vol. 141, no. 2, pp. 155–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. G. E. Piérard, C. Piérard-Franchimont, A. F. Nikkels, N. Nikkels-Tassoudji, J. E. Arrese, and J. P. Bourguignon, “Naevocyte triggering by recombinant human growth hormone,” Journal of Pathology, vol. 180, pp. 74–79, 1996.
  54. H. Kittler, M. Seltenheim, M. Dawid, H. Pehamberger, K. Wolff, and M. Binder, “Frequency and characteristics of enlarging common melanocytic nevi,” Archives of Dermatology, vol. 136, no. 3, pp. 316–320, 2000. View at Scopus
  55. J. Bauer, A. Blum, U. Strohhäcker, and C. Garbe, “Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy,” The British Journal of Dermatology, vol. 152, no. 1, pp. 87–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. S. Cross, A. J. G. McDonagh, T. J. Stephenson, D. W. K. Cotton, and J. C. E. Underwood, “Fractal and integer-dimensional geometric analysis of pigmented skin lesions,” The American Journal of Dermatopathology, vol. 17, no. 4, pp. 374–378, 1995. View at Scopus
  57. O. Heymans, S. Blacher, F. Brouers, and G. E. Piérard, “Fractal quantification of the microvasculature heterogeneity in cutaneous melanoma,” Dermatology, vol. 198, no. 2, pp. 212–217, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Piantanelli, P. Maponi, A. Cialabrini, L. Scalise, A. Basso, and S. Serresi, “Fractal charaterisation of boundary irregularity in skin pigmented lesions,” Medical and Biological Engineering and Computing, vol. 43, no. 4, pp. 436–442, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Petit, L. Fogouang, I. Uhoda, S. Smitz, C. Piérard-Franchimont, and G. E. Piérard, “Regional variability in mottled subclinical melanoderma in the elderly,” Experimental Gerontology, vol. 38, no. 3, pp. 327–331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Hermanns-Lê, C. Piérard-Franchimont, and G. E. Piérard, “Scrutinizing skinfield melanin patterns in young Caucasian women,” Expert Opinion on Medical Diagnostics, vol. 7, pp. 455–462, 2013. View at Publisher · View at Google Scholar